Articles
Engaging the unengaged in science? Try a little harder
The strange but true fact is: not everybody is absolutely fascinated by science, nor thinks it is vital. [ + ]
You are what you earn: chemical body burden reflects socioeconomic status
Using data from the US National Health and Nutrition Examination Survey, a research team analysed possible links between a person’s socioeconomic status and the prevalence of chemicals in their body. [ + ]
Five frequently asked questions about temperature and humidity validation/mapping
The US Food and Drug Administration’s (FDA) regulations tell us that we must identify the environmental conditions that can affect the strength, identity, safety, quality and purity of our regulated products, whether they are pharmaceuticals, medical devices or biologic products. The FDA regulations also say we must be able to demonstrate that we have maintained our product storage spaces such that the required storage conditions for our products have been met. [ + ]
Aussie biotechs must plan for weakened dollar
The Australian Life Sciences Index outperformed the All Ordinaries in Q4, and the weaker dollar presents both challenges and opportunities for the sector, according to the latest PwC report. [ + ]
Chronic inflammatory disease on trial
The results of clinical trial using cellular therapy in patients with Crohn’s disease were so encouraging the research was published before the trail had been completed. [ + ]
Bionomics signs up to US$172m deal with Merck
Bionomics (ASX:BNO) has entered a small molecule pain drug research and option agreement with pharmaceutical giant Merck that could be worth up to US$172m. [ + ]
Healthcare Management and Leadership unit launched at MGSM
Macquarie Graduate School of Management (MGSM) has launched a new unit for MBA students, ‘Healthcare Management and Leadership’, which will be offered for the first time in term four 2013 to those that wish to lead, govern or manage within the healthcare sector. [ + ]
Evolution is a group effort
Researchers have found that rather than just one mutation causing enhanced survival, about five to seven mutations are required. These extra mutations are termed ‘genetic hitchhikers’ because they don’t appear to contribute to the enhanced fitness of the organism. [ + ]
Phosphagenics moving to phase II for TPM/oxycodone
Phosphagenics (ASX:POH) will move on to phase II trials of its oxycodone patch product, after demonstrating sustained delivery in phase I. [ + ]
Exploring exotic energy
Combining the Standard Model of particle physics with Einstein’s general theory of relativity is a Holy Grail that is now being probed. [ + ]
BioDiem progresses liver disease vaccine
BioDiem (ASX: BDM) has announced its hepatitis vaccine program is making good progress. [ + ]
Aligning immunology and virology
Running a lab, directing a CRC and now a WHO Centre, Anne Kelso discusses her accomplished research career in microbiology, immunology and virology. [ + ]
Viralytics reports strong interim results for cancer treatment
Interim results look promising for Viralytic’s lead compound Cavatak. [ + ]
Weeing in space
When Alan Shepard, the first American to fly in space (5 May 1961) was forced to wee in his spacesuit, his urine short-circuited his electronic biosensors. Eight hours of launch delays had not been factored into his 15-minute spaceflight and there was no provision for him to urinate once kitted out in his spacesuit. [ + ]
Now they tell us - high omega-3 fatty acids levels increase risk of prostate cancer
Fatty acids derived from fatty fish and fish-oil supplements, usually lauded as ‘cure-alls’, have been found to increase the risk of developing aggressive prostate cancer. [ + ]